Status:
COMPLETED
Contribution of a Nurse Consultation in the Follow-up of At-risk Newborn at Maternity Discharged
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
At-risk Newborn
Eligibility:
All Genders
1+ years
Brief Summary
The postnatal period is a critical phase involving important physiological, psychological and social changes. Pediatric nurses could be a crucial actor in the follow-up of at-risk newborn, in collabor...
Detailed Description
The postnatal period is a critical phase involving important physiological, psychological and social changes. In 2013, WHO recommends at least three postnatal contacts on day 3, between days 7 and 14,...
Eligibility Criteria
Inclusion
- All at-risk newborns addressed to nurse consultation after discharge from maternity hospital.
- All at-risk newborns discharged home after hospitalization at birth in the neonatal medicine department.
Exclusion
- Newborns discharged with home hospitalization
- Consultation for hearing screening, blood testing or injection (vaccines or palivizumab).
- Newborns referred by pediatrics department, PED or by exterior professionals.
- Non-at-risk newborns hospitalized for other reasons (biological anoxia, early neonatal bacterial infection, transient tachypnea, monitoring)
Key Trial Info
Start Date :
May 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 11 2024
Estimated Enrollment :
1330 Patients enrolled
Trial Details
Trial ID
NCT05258916
Start Date
May 11 2022
End Date
July 11 2024
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, 91106